TOX2
TOX high mobility group box family member 2
Also known as: C20orf100, dJ1108D11.2, GCX-1, TOX2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96NM4
- Gene
- TOX2
- Ensembl
- ENSG00000124191
- Chromosome
- 20
- Canonical length
- 488 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Enables transcription coactivator activity. Involved in positive regulation of transcription by RNA polymerase II. Located in nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
488 residues, UniProt reviewed canonical sequence.
>Q96NM4|TOX2
1 MQQTRTEAVA GAFSRCLGFC GMRLGLLLLA RHWCIAGVFP QKFDGDSAYV GMSDGNPELL
61 STSQTYNGQS ENNEDYEIPP ITPPNLPEPS LLHLGDHEAS YHSLCHGLTP NGLLPAYSYQ
121 AMDLPAIMVS NMLAQDSHLL SGQLPTIQEM VHSEVAAYDS GRPGPLLGRP AMLASHMSAL
181 SQSQLISQMG IRSSIAHSSP SPPGSKSATP SPSSSTQEEE SEVHFKISGE KRPSADPGKK
241 AKNPKKKKKK DPNEPQKPVS AYALFFRDTQ AAIKGQNPSA TFGDVSKIVA SMWDSLGEEQ
301 KQSSPDQGET KSTQANPPAK MLPPKQPMYA MPGLASFLTP SDLQAFRSGA SPASLARTLG
361 SKSLLPGLSA SPPPPPSFPL SPTLHQQLSL PPHAQGALLS PPVSMSPAPQ PPVLPTPMAL
421 QVQLAMSPSP PGPQDFPHIS EFPSSSGSCS PGPSNPTSSG DWDSSYPSGE CGISTCSLLP
481 RDKSLYLTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TOX2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.68
- Highest tissue expression
- 47 nTPM
Expression across tissuesHPA
Tissue
- thymus: 47 nTPM
- hypothalamus: 30 nTPM
- lung: 30 nTPM
- pituitary gland: 21 nTPM
- midbrain: 19 nTPM
- cerebral cortex: 18 nTPM
Single-cell type
- corticotrophs: 266 nCPM
- innate lymphoid cells: 252 nCPM
- sertoli cells: 176 nCPM
- thyrotrophs: 131 nCPM
- lactotrophs: 84 nCPM
- oocytes: 83 nCPM
Immune cell
- eosinophil: 6.6 nTPM
- plasmacytoid DC: 2.6 nTPM
- T-reg: 1.2 nTPM
- NK-cell: 1.1 nTPM
- neutrophil: 0.7 nTPM
- memory CD4 T-cell: 0.3 nTPM
Brain region
- hypothalamus: 76 nTPM
- thalamus: 46 nTPM
- midbrain: 40 nTPM
- cerebral cortex: 38 nTPM
- pons: 34 nTPM
- medulla oblongata: 25 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.63
- gnomAD pLI
- 0.03
- gnomAD missense Z
- 0.59
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- positive regulation of transcription by RNA polymerase II
- regulation of transcription by RNA polymerase II
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TOX2 as an antibody target. Whether an autoantibody or antibody against TOX2 could matter depends on whether native TOX2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TOX2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TOX2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...